Effects of preoperative chemotherapy on neuroblastoma with MYCN amplification: a surgeon's perspective
Background Preoperative chemotherapy plays an important role in the surgical management of unresectable neuroblastoma. Its response to chemotherapy has been variable due to the tumor's heterogeneity. We aimed to evaluate the effects of preoperative chemotherapy on MYCN-amplified (MYCNA) neurobl...
Saved in:
Main Author: | Chanhon Chui (Author) |
---|---|
Format: | Book |
Published: |
BMJ Publishing Group,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential molecularly therapy target to MYCN‐amplificated neuroblastoma
by: Susu Jiang, et al.
Published: (2023) -
Impact of 11q Loss of Heterozygosity Status on the Response of High-Risk Neuroblastoma With MYCN Amplification to Neoadjuvant Chemotherapy
by: Xian-Ying Lu, et al.
Published: (2022) -
Exon array analysis reveals neuroblastoma tumors have distinct alternative splicing patterns according to stage and <it>MYCN </it>amplification status
by: Wei Jun S, et al.
Published: (2011) -
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma
by: Eunjin Lee, et al.
Published: (2020) -
MYCN protein stability is a better prognostic indicator in neuroblastoma
by: Yi Yang, et al.
Published: (2022)